← Leaderboards
Ahmed Abdel-Latif
Veterans Health Administration
$3,746,023
Attributed
$4,107,419
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $638.4K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,107,419 · 4
VA$0 · 1
By mechanism
R01$1,912,500 · 1
P20$1,277,616 · 1
R61$542,094 · 1
R56$375,209 · 1
I01$0 · 1
Top collaborators
- David Feola1 shared
- Rudolph C Johnson1 shared
- Vincent Joseph Venditto1 shared
Most similar at Veterans Health Administration
Same institution · by research overlap
- Changhyon Chris Yun$11,920,592
- Kejie Yin$6,302,196
- Raymond Harris$35,481,055
- Peter Wyman Wilson$258,319
- Kelly Cho$0
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayCardiacMouse ModelPlasmaLipidsPathway InteractionsSignal TransductionInjuryCardiac MyocytesSignal PathwayHeartMolecularRecoveryHomingChemokineResponseBaseMyocardial IschemiaBone MarrowAcute Myocardial InfarctionMyocardiumPeripheral BloodMortalityMyocardial
Grant awards (15)
Liposomal azithromycin to treat cardiac inflammation$542,094
R61 · FY2025 · HL
Lysophosphatidic acid mediates cardiac inflammation and heart failure with preserved ejection fraction$0
I01 · FY2025 · VA · contact PI
Lysophosphatidic acid mediates cardiac inflammation and heart failure with preserved ejection fraction$0
I01 · FY2024 · VA · contact PI
Lysophosphatidic Acid Mediates Cardiac Inflammation After Acute Infarction$207,663
R01 · FY2021 · HL · contact PI
Lysophosphatidic Acid Mediates Cardiac Inflammation After Acute Infarction$174,837
R01 · FY2021 · HL · contact PI
Lysophosphatidic Acid Mediates Cardiac Inflammation After Acute Infarction$382,500
R01 · FY2020 · HL · contact PI
Lysophosphatidic Acid Mediates Cardiac Inflammation After Acute Infarction$382,500
R01 · FY2019 · HL · contact PI
Lysophosphatidic Acid Mediates Cardiac Inflammation After Acute Infarction$382,500
R01 · FY2018 · HL · contact PI
Lysophosphatidic Acid Mediates Cardiac Inflammation After Acute Infarction$382,500
R01 · FY2017 · HL · contact PI
Role of bioactive lipids in the protective pathways of obesity in ischemic cardi$255,850
P20 · FY2017 · GM · contact PI
Role of bioactive lipids in the protective pathways of obesity in ischemic cardi$255,850
P20 · FY2016 · GM · contact PI
Role of bioactive lipids in the protective pathways of obesity in ischemic cardi$255,850
P20 · FY2015 · GM · contact PI
Role of Bioactive Lipids in Stem Cell Mobilization and Homing in Cardiac Ischemia$375,209
R56 · FY2014 · HL · contact PI
Role of bioactive lipids in the protective pathways of obesity in ischemic cardi$255,066
P20 · FY2014 · GM · contact PI
Role of bioactive lipids in the protective pathways of obesity in ischemic cardi$255,000
P20 · FY2013 · GM · contact PI